BeiGene Ltd. ADR (BGNE) Social Stream



BeiGene Ltd. ADR (BGNE): $194.57

2.96 (+1.54%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BGNE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 379

in industry

BEIGENE LTD (BGNE) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering BEIGENE LTD.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 5 $431 $343.3 $404.46 $207.71 94.72%
2022-01-06 6 $431 $283.3 $392.46 $207.71 88.95%
2022-01-12 6 $431 $283.3 $388.716 $207.71 87.14%
2022-01-18 6 $431 $283.3 $380.883 $207.71 83.37%
2022-01-28 6 $431 $283.3 $367.55 $207.71 76.95%
2022-02-08 6 $431 $283.3 $354.216 $207.71 70.53%
2022-02-25 6 $431 $283.3 $348.55 $207.71 67.81%
2022-02-28 6 $431 $254 $332.333 $207.71 60%
2022-03-17 6 $431 $177 $300.2 $207.71 44.53%
2022-04-28 6 $431 $177 $313.166 $207.71 50.77%
2022-05-06 6 $431 $177 $296.166 $207.71 42.59%
2022-05-18 6 $431 $177 $289.833 $207.71 39.54%
2022-07-27 6 $431 $177 $288.666 $207.71 38.98%
2022-08-05 6 $431 $177 $284.316 $207.71 36.88%
2022-08-09 6 $431 $177 $271.983 $207.71 30.94%
2022-09-17 6 $431 $177 $270.6 $207.71 30.28%
2022-10-03 6 $431 $177 $269.433 $207.71 29.72%
2022-10-13 6 $296 $200 $236.433 $207.71 13.83%
2022-11-14 6 $296 $205 $240.266 $207.71 15.67%

The Trend in the Analyst Price Target


BGNE's average price target has moved down $140.62 over the prior 43 weeks.

Over the past 45 weeks, BGNE's average upside potential has been 67.22%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-17 6 431 177 311.833 189.04 64.96%
2022-04-28 6 431 177 313.166 158.45 97.64%
2022-05-09 6 431 177 289.833 134.22 115.94%
2022-08-12 6 431 177 270.600 193.97 39.51%
2022-10-03 6 296 177 237.120 137.14 72.9%

BGNE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.33 5 0 1 0 0 6

The Trend in the Broker Recommendations


BGNE's average broker recommendation rating improved by 0.24 over the prior 32 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BGNE as an investment opportunity.

  • In terms of how BEIGENE LTD fares relative to all US stocks, note that its average analyst price target is greater than 2281.69% of that group.
  • BEIGENE LTD's number of analysts covering the stock is higher than 219.94% of stocks in the large market cap category.
  • BEIGENE LTD's upside potential (average analyst target price relative to current price) is higher than 618.11% of Pharmaceutical Products stocks.
  • BEIGENE LTD's variance in analysts' estimates is lower than -1294.69% of stocks in the large market cap category.

In the Pharmaceutical Products industry, GLPG, RARE, and ALKS are the three stocks most similar to BEIGENE LTD regarding the price target and analyst recommendation information presented here.

What is the outlook for BGNE? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6564 seconds.